About Scale Biosciences
Scale Biosciences was founded in 2020 and is headquartered in San Diego, United States. Operations focus on the biotechnology sector, where single-cell library preparation kits are developed using patented combinatorial indexing technology. These kits support genomic, epigenomic, and transcriptomic analysis to enable detailed biological studies. The company is led by co-founder Frank Steemers and CEO Giovanna Prout.
- Headquarter San Diego, United States
- Founders Frank Steemers
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
10X Genomics
(Aug 07, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Scale Biosciences
Unlock access to complete
Funding Insights of Scale Biosciences
Detailed funding history for Scale Biosciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Scale Biosciences
Scale Biosciences has secured backing from 1 investor. Prominent investors backing the company include 10X Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Instrument systems for genomic research and sequencing libraries are developed.
|
Locked | Locked | Locked |
Investor details for Scale Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Scale Biosciences
Investment portfolio details for Scale Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Scale Biosciences
Detailed financials for Scale Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Scale Biosciences Comparisons
Peer comparison for Scale Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Scale Biosciences
Detailed competitors of Scale Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Scale Biosciences
Complete news archive for Scale Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scale Biosciences
Scale Biosciences was founded in 2020.
Scale Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Giovanna Prout is the current CEO of Scale Biosciences.
Scale Biosciences was founded in 2020 and is headquartered in San Diego, United States. Operations focus on the biotechnology sector, where single-cell library preparation kits are developed using patented combinatorial indexing technology. These kits support genomic, epigenomic, and transcriptomic analysis to enable detailed biological studies. The company is led by co-founder Frank Steemers and CEO Giovanna Prout.
Scale Biosciences has 1 investor. Key investors include 10X Genomics.